S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL
| Published in: | HemaSphere |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843404.12756.f4 |
| _version_ | 1850051637688664064 |
|---|---|
| author | N. Russell C. Wilhelm-Benartzi S. Knapper L. Batten J Canham E. Hinson U. Malthe Overgaard J. Othman R. Dillon P. Mehta P. Kottaridis J. Cavenagh C. Hemmaway C. Arnold M. Dennis |
| author_facet | N. Russell C. Wilhelm-Benartzi S. Knapper L. Batten J Canham E. Hinson U. Malthe Overgaard J. Othman R. Dillon P. Mehta P. Kottaridis J. Cavenagh C. Hemmaway C. Arnold M. Dennis |
| author_sort | N. Russell |
| collection | DOAJ |
| container_title | HemaSphere |
| format | Article |
| id | doaj-art-eae52e8b0eaa408bb51120d045efd2bd |
| institution | Directory of Open Access Journals |
| issn | 2572-9241 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| spelling | doaj-art-eae52e8b0eaa408bb51120d045efd2bd2025-08-20T00:26:41ZengWileyHemaSphere2572-92412022-06-016293010.1097/01.HS9.0000843404.12756.f4202206003-00029S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIALN. Russell0C. Wilhelm-Benartzi1S. Knapper2L. Batten3J Canham4E. Hinson5U. Malthe Overgaard6J. Othman7R. Dillon8P. Mehta9P. Kottaridis10J. Cavenagh11C. Hemmaway12C. Arnold13M. Dennis141 Guy’s and St Thomas’ NHS Foundation Trust, Department of Haematology, London2 Centre for Trials Research3 School of Medicine, Cardiff University, Cardiff, United Kingdom2 Centre for Trials Research2 Centre for Trials Research2 Centre for Trials Research4 Copenhagen University Hospital, Copenhagen, Denmark5 Department of Medical and Molecular Genetics, Kings College London, London5 Department of Medical and Molecular Genetics, Kings College London, London6 University Hospitals of Bristol and Weston NHS Trust, Bristol7 University College London Hospitals NHS Foundation Trust8 Department of Haematology, St Bartholomew’s Hospital, London, United Kingdom9 Aukland Hospital, Aukland, New Zealand10 Belfast City Hospital, Belfast11 The Christie NHS Foundation Trust. On behalf of the NCRI AML Working Group, Manchester, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000843404.12756.f4 |
| spellingShingle | N. Russell C. Wilhelm-Benartzi S. Knapper L. Batten J Canham E. Hinson U. Malthe Overgaard J. Othman R. Dillon P. Mehta P. Kottaridis J. Cavenagh C. Hemmaway C. Arnold M. Dennis S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title | S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title_full | S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title_fullStr | S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title_full_unstemmed | S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title_short | S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL |
| title_sort | s128 a randomised comparison of cpx 351 and flag ida in high risk acute myeloid leukaemia results from the ncri aml19 trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000843404.12756.f4 |
| work_keys_str_mv | AT nrussell s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT cwilhelmbenartzi s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT sknapper s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT lbatten s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT jcanham s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT ehinson s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT umaltheovergaard s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT jothman s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT rdillon s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT pmehta s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT pkottaridis s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT jcavenagh s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT chemmaway s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT carnold s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial AT mdennis s128arandomisedcomparisonofcpx351andflagidainhighriskacutemyeloidleukaemiaresultsfromthencriaml19trial |